Hillsdale Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-224
| Closed | -$10K | – | 599 |
|
|
2020
Q4 | $10K | Buy |
224
+24
| +12% | +$1.07K | ﹤0.01% | 495 |
|
|
2020
Q3 | $9K | Buy |
200
+96
| +92% | +$4.32K | ﹤0.01% | 497 |
|
|
2020
Q2 | $5K | Sell |
104
-24
| -19% | -$1.15K | ﹤0.01% | 505 |
|
|
2020
Q1 | $6K | Hold |
128
| – | – | ﹤0.01% | 507 |
|
|
2019
Q4 | $8K | Hold |
128
| – | – | ﹤0.01% | 499 |
|
|
2019
Q3 | $7K | Buy |
128
+40
| +45% | +$2.19K | ﹤0.01% | 521 |
|
|
2019
Q2 | $4K | Buy |
88
+16
| +22% | +$727 | ﹤0.01% | 549 |
|
|
2019
Q1 | $4K | Buy |
72
+16
| +29% | +$889 | ﹤0.01% | 543 |
|
|
2018
Q4 | $3K | Sell |
56
-8
| -13% | -$429 | ﹤0.01% | 528 |
|
|
2018
Q3 | $3K | Buy |
64
+8
| +14% | +$375 | ﹤0.01% | 431 |
|
|
2018
Q2 | $3K | Sell |
56
-8
| -13% | -$429 | ﹤0.01% | 447 |
|
|
2018
Q1 | $3K | Sell |
64
-8
| -11% | -$375 | ﹤0.01% | 417 |
|
|
2017
Q4 | $3K | Sell |
72
-32
| -31% | -$1.33K | ﹤0.01% | 429 |
|
|
2017
Q3 | $5K | Buy |
+104
| New | +$5K | ﹤0.01% | 393 |
|
|
2015
Q4 | – | Sell |
-2,560
| Closed | -$123K | – | 533 |
|
|
2015
Q3 | $123K | Sell |
2,560
-80
| -3% | -$3.84K | 0.04% | 377 |
|
|
2015
Q2 | $137K | Buy |
2,640
+640
| +32% | +$33.2K | 0.04% | 378 |
|
|
2015
Q1 | $115K | Buy |
2,000
+480
| +32% | +$27.6K | 0.03% | 386 |
|
|
2014
Q4 | $81K | Sell |
1,520
-80
| -5% | -$4.26K | 0.02% | 419 |
|
|
2014
Q3 | $92K | Sell |
1,600
-800
| -33% | -$46K | 0.03% | 391 |
|
|
2014
Q2 | $160K | Sell |
2,400
-560
| -19% | -$37.3K | 0.04% | 355 |
|
|
2014
Q1 | $198K | Sell |
2,960
-4,320
| -59% | -$289K | 0.06% | 316 |
|
|
2013
Q4 | $486K | Buy |
7,280
+1,320
| +22% | +$88.1K | 0.14% | 105 |
|
|
2013
Q3 | $374K | Buy |
5,960
+2,600
| +77% | +$163K | 0.11% | 134 |
|
|
2013
Q2 | $210K | Buy |
+3,360
| New | +$210K | 0.07% | 285 |
|